Takis

From every crisis there is an opportunity… this is our story in a nutshell - wonderfully reported by #RaiNews in this segment! Our company was born from the hashes of layoffs from multinational companies. But it turned out to be the spark for an exciting journey. After 15 years, we are proud to have inaugurated an innovative BSL-3 lab as well as produced impactful research on genetic vaccines and immunotherapies. Our COO, Emanuele Marra, provided insights into the new BSL-3 facility, explaining how it enables researchers to “study highly dangerous pathogens and develop the best therapies.” Also our CEO, Luigi Aurisicchio, talked about Takis’ story, discussing our team’s commitment and resilience, creating the innovative company we are today. Luciano Mocci, General Director of Federlazio - Associazione Piccole e Medie Imprese del Lazio and Board Director of Tecnopolo Roma, finally added how this area just outside Rome has become over time a leading hub for cutting-edge innovation and research. A heartfelt thanks to Rai News for this opportunity to share our work and vision with a wider audience! #tecnopolo #federlazio #research #innovation #pharma

Takis is thrilled to have participated with a poster in Europe’s largest event on #vaccine R&D! From the 28th to the 31st of October, the The World Vaccine Congress Europe 2024 gathered in Barcelona world-leading experts who explored the latest advances in vaccine technology, epidemic preparedness, therapies, zoonotic disease research, and more. With over 3,000 attendees, we had invaluable opportunities to network, gain insights from top innovators, and share our perspectives on the future of vaccine research. The Congress featured dynamic sessions like the Start-up Zone, Poster Zone, and new Working Groups, where group discussions allowed us to connect more with other professionals. We also presented a poster on the Development of Novel Genetic Vaccine Platforms: From the Idea to GMP Production, which we will share soon also here on LinkedIn. If you want to check it out, follow our LinkedIn page to stay updated!

Yesterday we had the pleasure to welcome to our facilities a delegation from Regione Lazio's Economic Development Council, led by the Ass. Roberta Angelilli, and by the BoD of the Tecnopolo Roma. During the visit, our guests had the opportunity to explore Takis’ state-of-the-art infrastructure, including our newly inaugurated BSL-3 lab, a key asset for advancing our #research. Visits like these play a vital role in enhancing #cooperation between the scientific community and #institutions. They create valuable moments for in-depth discussions on pivotal projects, groundbreaking innovations, and the challenges that drive our work forward. We extend our heartfelt gratitude to Roberta Angelilli and her team for their dedication and commitment to supporting our efforts. Collaborating with institutions is essential to accelerating scientific and technological advancements in the Lazio Region. We’re excited to build on this shared vision and continue contributing to the regional progress and innovation. #tecnopolo #regionelazio

Hear our CEO, Luigi Aurisicchio, speak about our newly inaugurated BSL-3 laboratory during Maker Faire Rome - The European Edition ! Our CEO discussed our work and #research, focusing in particular on our work to improve the #epidemicpreparedness. With our new BSL-3 laboratory, a state-of-the-art #facility, we can work on innovative research on a wide range of pathogens. The topic captured the attention of many participants and professionals attending the fair, providing an important opportunity to share knowledge and connect with people from various sectors. Check out Takis’ snapshot from the YouTube Maker Faire Rome page!

We had recently the honor of participating in the “Maker Faire Rome - The European Edition”, a major #event that celebrates innovation and creativity, bringing together businesses and enthusiasts from different sectors! Promoted by the Camera di Commercio Roma and organized by Innova Camera, Maker Faire Rome was a unique meeting point for companies, start-ups and students, bringing together a modern and visionary approach in doing business. On this occasion, our CEO, Luigi Aurisicchio, gave an inspiring #speech dedicated to our newly inaugurated BSL-3 laboratory. We are grateful to have participated at this important fair; we had the opportunity to bring our vision and mission to a wider audience, connecting with many companies from different sectors.

In the #MIRIA project, Takis is responsible for evaluating the #antiviral properties of nanocoatings by measuring the residual infectivity of #viral pathogens on eukaryotic cells after prolonged incubation with coated or uncoated materials at different temperature conditions. So far, Takis optimized an antiviral assay to check the properties of tested #nanocoatings against an engineered adenovirus able to be detected for measurement of viral activity. We recently had the chance to participate in the 5th Consortium Meeting of the MIRIA EU project, hosted in Grenoble by CEA, where we shared our latest results, contributing to the identification of the best nanocoatings candidates. MIRIA is an ambitious initiative focused on the development of antimicrobial, antiviral, and antifungal nanocoatings for everyday surfaces, with the goal of enhancing public #safety in environments where the risk of cross-contamination is high. We are excited to continue pushing the boundaries of science with our other EU partners, creating solutions that have the potential to significantly impact public #health across Europe!

Takis participated in the Festival of Biologics 2024, from October 15th to 17th at Messe Basel, Switzerland! This prestigious #event brought together top professionals from the #biologics industry, covering the entire value chain—from discovery and development to clinical trials, manufacturing, and market access. Our Takis members, Alessia Muzi and Giuseppe Roscilli joined a round table discussion on “Bispecific #antibody engineering: challenges and strategies,” where they shared their #insights and #expertise in this groundbreaking field. Events like the Festival of Biologics provide a vital platform to bridge the gap between academia and industry, driving the latest advancements in biologics. We look forward to the new #collaborations and ideas generated to events like this as we continue our mission in biomedical #research!

On October 25th, Takis had the honor of participating among a selected group of Italian companies in the “Italy-China Workshop: Globalization, Borders, and Identity”! The #event has been organized by the Camera di Commercio Roma and the Foundation for International Studies and Geopolitics, in collaboration with the Embassy of the People's Republic of China in Italy. It brought together leading companies from #Italy and #China in various industrial sectors, including the #Pharmaceutical one. It was a privilege for Takis to be part of this event, exploring potential collaborations and opportunities in the Chinese market. We look forward to building meaningful partnerships and expanding our global network! Tecnopolo Roma

At Takis, we put our heart and soul into our mission… and seeing that 7,000 people #follow our efforts here on this platform is an incredible honor. We are truly grateful for the support of each and every one of you. Your #engagement and interest drive us forward as we continue to innovate in the fields of #biotechnology, #cancer #research, and epidemic preparedness. Thank you for being part of this incredible journey on #LinkedIn! 7.000 Grazie!

From October 2nd to 4th, Takis had the opportunity to participate in the 30th National Congress of AISAL, the Italian Association for Laboratory Animal Science! The congress took place at the CNR conference hall and, in its 30th edition, addressed the theme of complementarity and integration of methodologies, regulations, and expertise in preclinical research involving the use of #laboratoryanimals. Representing Takis were our Animal Welfare Officer, Fabiana Fosca Ferrara, and researcher Manuela Cappelletti. During the event, we had the chance to attend notable presentations and speeches, including those by Dr. Maylander, DGSA from the Ministero della Salute, and Dr. Panzini from the Istituto Superiore di Sanità, who discussed the challenges faced by auditors, as well as Dr. Limatola from CNPA, who spoke about the interactions between CNPA and OPBA. We would also like to mention Dr. D'Amore from the ISS, a prominent figure in our field, who served as a moderator for one of the conference sessions. Additionally, we had the pleasure of meeting veterinarian VINCENZO PENTELLA, a valuable ally in scientific research. This autumn has been filled with significant scientific meetings, offering unique opportunities for discussion, learning, and strengthening our expertise in such a delicate and crucial area as preclinical research. We look forward to continuing our participation in high-caliber events like this, reinforcing our commitment to advancing biomedical research.